ECOR1 CAPITAL, LLC Holdings

ECOR1 CAPITAL, LLC is an investment fund managing more than 3.39B US dollars. The largest holdings include Prothena Corporation, Apellis Pharmaceuticals and Sarepta Therapeutics. In Q3 2022 the fund bought assets of total value of 438.02M US dollars and sold assets of total value of 426.82M US dollars.

$3.38B

portfolio value

+21.29%

quarter

-35.44%

1 year

-38.88%

3 years

-31.61%

5 years

ECOR1 CAPITAL, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	55873000	47713000
Q2 2016	71982000	86079000
Q3 2016	97701000	60713000
Q4 2016	86021000	49500000
Q1 2017	88467000	87627000
Q2 2017	141646000	48529000
Q3 2017	296136000	68085000
Q4 2017	159383000	174382000
Q1 2018	198673000	41692000
Q2 2018	293611000	252840000
Q3 2018	213814000	152273000
Q4 2018	243501000	336970000
Q1 2019	244949000	253890000
Q2 2019	228955000	198985000
Q3 2019	148606000	343228000
Q4 2019	354426000	63183000
Q1 2020	200614000	225116000
Q2 2020	701067000	343795000
Q3 2020	253903000	310815000
Q4 2020	516057000	213070000
Q1 2021	659999000	97642000
Q2 2021	593559000	78060000
Q3 2021	371513000	359719000
Q4 2021	811174000	226615000
Q1 2022	865369000	633799000
Q2 2022	408986000	333381000
Q3 2022	438019000	426815000

ECOR1 CAPITAL, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Prothena Corporation plc Portfolio share: 20.73% Portfolio value: 702.35M Avg. open price: $12.14 Current price: $60.39 P/L: +397.27% Bought +2.66% shares Q1 2022	share	20.73%	702.35M	$12.14	$60.39	+397.27%	Bought +2.66% shares Q1 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 10.45% Portfolio value: 354.02M Avg. open price: $47.95 Current price: $49.41 P/L: +3.03% Bought +28.50% shares Q1 2022	share	10.45%	354.02M	$47.95	$49.41	+3.03%	Bought +28.50% shares Q1 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 9.79% Portfolio value: 331.56M Avg. open price: $77.67 Current price: $122.96 P/L: +58.30% Bought +4.58% shares Q3 2022	share	9.79%	331.56M	$77.67	$122.96	+58.30%	Bought +4.58% shares Q3 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 5.66% Portfolio value: 191.86M Avg. open price: $20.46 Current price: $28.65 P/L: +40.01% Bought +5.17% shares Q2 2021	share	5.66%	191.86M	$20.46	$28.65	+40.01%	Bought +5.17% shares Q2 2021
Biotechnology Arvinas, Inc. Portfolio share: 4.10% Portfolio value: 138.95M Avg. open price: $71.15 Current price: $39.53 P/L: -44.44% Bought +107.68% shares Q2 2022	share	4.10%	138.95M	$71.15	$39.53	-44.44%	Bought +107.68% shares Q2 2022
Biotechnology Xencor, Inc. Portfolio share: 4.05% Portfolio value: 137.24M Avg. open price: $32.97 Current price: $29.54 P/L: -10.41% Bought 0.00% shares Q3 2022	share	4.05%	137.24M	$32.97	$29.54	-10.41%	Bought 0.00% shares Q3 2022
Biotechnology Galapagos NV Portfolio share: 4.02% Portfolio value: 136.34M Avg. open price: $54.25 Current price: $38.92 P/L: -28.25% Bought +0.06% shares Q2 2022	share	4.02%	136.34M	$54.25	$38.92	-28.25%	Bought +0.06% shares Q2 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 3.30% Portfolio value: 111.82M Avg. open price: $43.05 Current price: $26.56 P/L: -38.30% Bought +31.75% shares Q2 2021	share	3.30%	111.82M	$43.05	$26.56	-38.30%	Bought +31.75% shares Q2 2021
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 2.91% Portfolio value: 98.72M Avg. open price: N/A Current price: $24.25 P/L: N/A N/A Q3 2022	share	2.91%	98.72M	N/A	$24.25	N/A	N/A Q3 2022
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 2.89% Portfolio value: 98.02M Avg. open price: $23.54 Current price: $15.24 P/L: -35.26% Bought +95.76% shares Q1 2022	share	2.89%	98.02M	$23.54	$15.24	-35.26%	Bought +95.76% shares Q1 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 2.75% Portfolio value: 93.14M Avg. open price: $30.71 Current price: $18.36 P/L: -40.22% Bought +11.82% shares Q3 2022	share	2.75%	93.14M	$30.71	$18.36	-40.22%	Bought +11.82% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 2.68% Portfolio value: 90.68M Avg. open price: $16.97 Current price: $15.82 P/L: -6.80% Bought +78.24% shares Q1 2022	share	2.68%	90.68M	$16.97	$15.82	-6.80%	Bought +78.24% shares Q1 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 2.09% Portfolio value: 70.92M Avg. open price: $86.01 Current price: $92.75 P/L: +7.84% N/A Q3 2022	share	2.09%	70.92M	$86.01	$92.75	+7.84%	N/A Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 2.05% Portfolio value: 69.43M Avg. open price: $31.42 Current price: $33.74 P/L: +7.37% Sold -16.52% shares Q3 2022	share	2.05%	69.43M	$31.42	$33.74	+7.37%	Sold -16.52% shares Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 1.47% Portfolio value: 49.84M Avg. open price: N/A Current price: $9.29 P/L: N/A N/A Q3 2022	share	1.47%	49.84M	N/A	$9.29	N/A	N/A Q3 2022
Biotechnology Allogene Therapeutics, Inc. Portfolio share: 1.43% Portfolio value: 48.47M Avg. open price: N/A Current price: $9.37 P/L: N/A N/A Q2 2022	share	1.43%	48.47M	N/A	$9.37	N/A	N/A Q2 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 1.40% Portfolio value: 47.34M Avg. open price: $22.92 Current price: $11.18 P/L: -51.22% Bought +5.07% shares Q3 2022	share	1.40%	47.34M	$22.92	$11.18	-51.22%	Bought +5.07% shares Q3 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 1.24% Portfolio value: 42.12M Avg. open price: $19.25 Current price: $13.67 P/L: -28.98% Sold -4.36% shares Q3 2022	share	1.24%	42.12M	$19.25	$13.67	-28.98%	Sold -4.36% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 1.15% Portfolio value: 39.10M Avg. open price: $51.74 Current price: $121.22 P/L: +134.29% Sold -71.67% shares Q3 2022	share	1.15%	39.10M	$51.74	$121.22	+134.29%	Sold -71.67% shares Q3 2022
Biotechnology Alector, Inc. Portfolio share: 1.13% Portfolio value: 38.37M Avg. open price: $20.35 Current price: $8.68 P/L: -57.35% Sold -29.31% shares Q2 2022	share	1.13%	38.37M	$20.35	$8.68	-57.35%	Sold -29.31% shares Q2 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 1.05% Portfolio value: 35.53M Avg. open price: $25.51 Current price: $24.32 P/L: -4.66% Sold -57.88% shares Q3 2022	share	1.05%	35.53M	$25.51	$24.32	-4.66%	Sold -57.88% shares Q3 2022
Biotechnology Atea Pharmaceuticals, Inc. Portfolio share: 1.04% Portfolio value: 35.19M Avg. open price: $9.05 Current price: $4.67 P/L: -48.40% Sold -2.46% shares Q3 2022	share	1.04%	35.19M	$9.05	$4.67	-48.40%	Sold -2.46% shares Q3 2022
Biotechnology Edgewise Therapeutics, Inc. Portfolio share: 1.01% Portfolio value: 34.37M Avg. open price: $11.55 Current price: $8.83 P/L: -23.53% Bought +48.03% shares Q3 2022	share	1.01%	34.37M	$11.55	$8.83	-23.53%	Bought +48.03% shares Q3 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 1.01% Portfolio value: 34.06M Avg. open price: $25.92 Current price: $15.36 P/L: -40.74% Sold -33.03% shares Q3 2022	share	1.01%	34.06M	$25.92	$15.36	-40.74%	Sold -33.03% shares Q3 2022
Biotechnology Nuvation Bio Inc. Portfolio share: 0.92% Portfolio value: 31.12M Avg. open price: $10.26 Current price: $1.94 P/L: -81.08% Bought +1.35% shares Q4 2021	share	0.92%	31.12M	$10.26	$1.94	-81.08%	Bought +1.35% shares Q4 2021
Biotechnology Voyager Therapeutics, Inc. Portfolio share: 0.83% Portfolio value: 28.14M Avg. open price: $4.02 Current price: $6.27 P/L: +56.13% Bought +33.63% shares Q2 2022	share	0.83%	28.14M	$4.02	$6.27	+56.13%	Bought +33.63% shares Q2 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 0.77% Portfolio value: 26.12M Avg. open price: $19.97 Current price: $18.32 P/L: -8.24% Bought +68.34% shares Q2 2022	share	0.77%	26.12M	$19.97	$18.32	-8.24%	Bought +68.34% shares Q2 2022
Biotechnology Janux Therapeutics, Inc. Portfolio share: 0.57% Portfolio value: 19.24M Avg. open price: $19.89 Current price: $13.5 P/L: -32.13% Bought +0.66% shares Q1 2022	share	0.57%	19.24M	$19.89	$13.5	-32.13%	Bought +0.66% shares Q1 2022
Biotechnology Kymera Therapeutics, Inc. Portfolio share: 0.51% Portfolio value: 17.33M Avg. open price: $38.86 Current price: $29.11 P/L: -25.09% N/A Q3 2022	share	0.51%	17.33M	$38.86	$29.11	-25.09%	N/A Q3 2022
Biotechnology Tango Therapeutics, Inc. Portfolio share: 0.45% Portfolio value: 15.20M Avg. open price: $5.9 Current price: $7.69 P/L: +30.43% Bought +82.51% shares Q3 2022	share	0.45%	15.20M	$5.9	$7.69	+30.43%	Bought +82.51% shares Q3 2022
Biotechnology Cullinan Oncology, Inc. Portfolio share: 0.43% Portfolio value: 14.65M Avg. open price: N/A Current price: $11.61 P/L: N/A Sold -2.28% shares Q3 2022	share	0.43%	14.65M	N/A	$11.61	N/A	Sold -2.28% shares Q3 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 0.41% Portfolio value: 13.96M Avg. open price: N/A Current price: $28.09 P/L: N/A Sold -69.23% shares Q3 2022	share	0.41%	13.96M	N/A	$28.09	N/A	Sold -69.23% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 0.40% Portfolio value: 13.56M Avg. open price: N/A Current price: $22.77 P/L: N/A N/A Q1 2022	share	0.40%	13.56M	N/A	$22.77	N/A	N/A Q1 2022
Biotechnology Akouos, Inc. Portfolio share: 0.39% Portfolio value: 13.35M Avg. open price: N/A Current price: $13.29 P/L: N/A N/A Q2 2020	share	0.39%	13.35M	N/A	$13.29	N/A	N/A Q2 2020
Biotechnology Centessa Pharmaceuticals plc Portfolio share: 0.38% Portfolio value: 13.01M Avg. open price: $4.87 Current price: $3.93 P/L: -19.30% Bought +1007.13% shares Q3 2022	share	0.38%	13.01M	$4.87	$3.93	-19.30%	Bought +1007.13% shares Q3 2022
Biotechnology Ovid Therapeutics Inc. Portfolio share: 0.33% Portfolio value: 11.25M Avg. open price: $3.17 Current price: $1.79 P/L: -43.53% Bought +0.58% shares Q1 2022	share	0.33%	11.25M	$3.17	$1.79	-43.53%	Bought +0.58% shares Q1 2022
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 0.32% Portfolio value: 10.93M Avg. open price: $21.67 Current price: $4.02 P/L: -81.45% Sold -1.47% shares Q1 2022	share	0.32%	10.93M	$21.67	$4.02	-81.45%	Sold -1.47% shares Q1 2022
Biotechnology Poseida Therapeutics, Inc. Portfolio share: 0.28% Portfolio value: 9.35M Avg. open price: N/A Current price: $5.1 P/L: N/A N/A Q3 2022	share	0.28%	9.35M	N/A	$5.1	N/A	N/A Q3 2022
Biotechnology Arcutis Biotherapeutics, Inc. Portfolio share: 0.23% Portfolio value: 7.93M Avg. open price: N/A Current price: $17.35 P/L: N/A Sold -53.62% shares Q3 2022	share	0.23%	7.93M	N/A	$17.35	N/A	Sold -53.62% shares Q3 2022
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 0.21% Portfolio value: 7.07M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q1 2022	share	0.21%	7.07M	N/A	$5.6	N/A	N/A Q1 2022
Biotechnology HOOKIPA Pharma Inc. Portfolio share: 0.20% Portfolio value: 6.7M Avg. open price: N/A Current price: $0.95 P/L: N/A N/A Q1 2022	share	0.20%	6.7M	N/A	$0.95	N/A	N/A Q1 2022
Biotechnology Precision BioSciences, Inc. Portfolio share: 0.19% Portfolio value: 6.54M Avg. open price: N/A Current price: $1.24 P/L: N/A N/A Q2 2022	share	0.19%	6.54M	N/A	$1.24	N/A	N/A Q2 2022
Biotechnology argenx SE Portfolio share: 0.18% Portfolio value: 6.18M Avg. open price: N/A Current price: $393.21 P/L: N/A Sold -85.98% shares Q3 2022	share	0.18%	6.18M	N/A	$393.21	N/A	Sold -85.98% shares Q3 2022
Biotechnology Gracell Biotechnologies Inc. Portfolio share: 0.18% Portfolio value: 6.18M Avg. open price: $2.33 Current price: $2.87 P/L: +23.18% Bought +23.18% shares Q2 2022	share	0.18%	6.18M	$2.33	$2.87	+23.18%	Bought +23.18% shares Q2 2022
Biotechnology Selecta Biosciences, Inc. Portfolio share: 0.17% Portfolio value: 5.74M Avg. open price: N/A Current price: $1.31 P/L: N/A N/A Q2 2022	share	0.17%	5.74M	N/A	$1.31	N/A	N/A Q2 2022
Biotechnology Geron Corporation Portfolio share: 0.16% Portfolio value: 5.38M Avg. open price: N/A Current price: $2.29 P/L: N/A Sold -83.75% shares Q3 2022	share	0.16%	5.38M	N/A	$2.29	N/A	Sold -83.75% shares Q3 2022
Biotechnology AVEO Pharmaceuticals, Inc. Portfolio share: 0.16% Portfolio value: 5.35M Avg. open price: $6.56 Current price: $14.91 P/L: +127.29% Bought +0.46% shares Q3 2022	share	0.16%	5.35M	$6.56	$14.91	+127.29%	Bought +0.46% shares Q3 2022
Biotechnology Erasca, Inc. Portfolio share: 0.16% Portfolio value: 5.29M Avg. open price: N/A Current price: $7.28 P/L: N/A Sold -3.08% shares Q1 2022	share	0.16%	5.29M	N/A	$7.28	N/A	Sold -3.08% shares Q1 2022
Biotechnology Graphite Bio, Inc. Portfolio share: 0.15% Portfolio value: 5.01M Avg. open price: $6.75 Current price: $3.59 P/L: -46.85% Bought +36.14% shares Q3 2022	share	0.15%	5.01M	$6.75	$3.59	-46.85%	Bought +36.14% shares Q3 2022
Shell Companies Jiya Acquisition Corp. Portfolio share: 0.15% Portfolio value: 4.98M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.15%	4.98M	N/A	$10.04	N/A	N/A Q4 2020
Shell Companies Frazier Lifesciences Acquisition Corporation Portfolio share: 0.14% Portfolio value: 4.86M Avg. open price: N/A Current price: $9.87 P/L: N/A Sold -17.02% shares Q3 2022	share	0.14%	4.86M	N/A	$9.87	N/A	Sold -17.02% shares Q3 2022
Biotechnology Aligos Therapeutics, Inc. Portfolio share: 0.13% Portfolio value: 4.34M Avg. open price: $11.97 Current price: $0.97 P/L: -91.92% Bought +4236.76% shares Q1 2022	share	0.13%	4.34M	$11.97	$0.97	-91.92%	Bought +4236.76% shares Q1 2022
Biotechnology Surface Oncology, Inc. Portfolio share: 0.12% Portfolio value: 4.08M Avg. open price: $4.79 Current price: $0.91 P/L: -80.93% Sold -15.65% shares Q3 2022	share	0.12%	4.08M	$4.79	$0.91	-80.93%	Sold -15.65% shares Q3 2022
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.12% Portfolio value: 3.96M Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q3 2020	share	0.12%	3.96M	N/A	$9.96	N/A	N/A Q3 2020
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 0.10% Portfolio value: 3.39M Avg. open price: $2.45 Current price: $2.14 P/L: -12.65% Bought +612.20% shares Q3 2022	share	0.10%	3.39M	$2.45	$2.14	-12.65%	Bought +612.20% shares Q3 2022
Biotechnology MacroGenics, Inc. Portfolio share: 0.10% Portfolio value: 3.22M Avg. open price: $19.15 Current price: $6.38 P/L: -66.68% N/A Q3 2022	share	0.10%	3.22M	$19.15	$6.38	-66.68%	N/A Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.08% Portfolio value: 2.80M Avg. open price: $24.55 Current price: $119.41 P/L: +386.39% N/A Q3 2022	share	0.08%	2.80M	$24.55	$119.41	+386.39%	N/A Q3 2022
NUVATION BIO INC Portfolio share: 0.06% Portfolio value: 2.15M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.06%	2.15M	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.06% Portfolio value: 2.09M Avg. open price: $23.28 Current price: $7.05 P/L: -69.72% Bought +600.00% shares Q3 2021	share	0.06%	2.09M	$23.28	$7.05	-69.72%	Bought +600.00% shares Q3 2021
Shell Companies Eucrates Biomedical Acquisition Corp. Portfolio share: 0.06% Portfolio value: 2.00M Avg. open price: N/A Current price: $9.92 P/L: N/A N/A Q1 2021	share	0.06%	2.00M	N/A	$9.92	N/A	N/A Q1 2021
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.06% Portfolio value: 2.00M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.06%	2.00M	N/A	$10.04	N/A	N/A Q4 2020
Shell Companies 5:01 Acquisition Corp. Portfolio share: 0.06% Portfolio value: 2M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q4 2020	share	0.06%	2M	N/A	$10	N/A	N/A Q4 2020
Biotechnology Tempest Therapeutics, Inc. Portfolio share: 0.05% Portfolio value: 1.79M Avg. open price: N/A Current price: $1.65 P/L: N/A N/A Q2 2022	share	0.05%	1.79M	N/A	$1.65	N/A	N/A Q2 2022
Shell Companies ARYA Sciences Acquisition Corp IV Portfolio share: 0.04% Portfolio value: 1.48M Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q1 2021	share	0.04%	1.48M	N/A	$10.05	N/A	N/A Q1 2021
Biotechnology Kronos Bio, Inc. Portfolio share: 0.03% Portfolio value: 1.09M Avg. open price: N/A Current price: $1.77 P/L: N/A Sold -15.64% shares Q1 2022	share	0.03%	1.09M	N/A	$1.77	N/A	Sold -15.64% shares Q1 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 0.03% Portfolio value: 1.06M Avg. open price: $19.25 Current price: $13.67 P/L: -28.98% N/A Q3 2022	call	0.03%	1.06M	$19.25	$13.67	-28.98%	N/A Q3 2022
Shell Companies Turmeric Acquisition Corp. Portfolio share: 0.03% Portfolio value: 1M Avg. open price: N/A Current price: $10.03 P/L: N/A N/A Q1 2021	share	0.03%	1M	N/A	$10.03	N/A	N/A Q1 2021
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 0.03% Portfolio value: 967K Avg. open price: N/A Current price: $39.62 P/L: N/A Sold -98.05% shares Q3 2022	share	0.03%	967K	N/A	$39.62	N/A	Sold -98.05% shares Q3 2022
Biotechnology Nuvalent, Inc. Portfolio share: 0.02% Portfolio value: 796K Avg. open price: N/A Current price: $34.16 P/L: N/A N/A Q3 2022	share	0.02%	796K	N/A	$34.16	N/A	N/A Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 0.02% Portfolio value: 771K Avg. open price: $32.03 Current price: $20.04 P/L: -37.42% Sold -85.54% shares Q3 2022	share	0.02%	771K	$32.03	$20.04	-37.42%	Sold -85.54% shares Q3 2022
CAREMAX INC Portfolio share: 0.02% Portfolio value: 709K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.02%	709K	N/A	N/A	N/A	N/A Q2 2021
EUCRATES BIOMEDICAL ACQU COR Portfolio share: 0.02% Portfolio value: 668K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.02%	668K	N/A	N/A	N/A	N/A Q2 2022
FRAZIER LIFESCIENCES ACQU CO Portfolio share: 0.02% Portfolio value: 665K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.02%	665K	N/A	N/A	N/A	N/A Q2 2021
Shell Companies Omega Alpha SPAC Portfolio share: 0.01% Portfolio value: 497K Avg. open price: N/A Current price: $10.06 P/L: N/A N/A Q1 2021	share	0.01%	497K	N/A	$10.06	N/A	N/A Q1 2021
TURMERIC ACQUISITION CORP Portfolio share: 0.01% Portfolio value: 333K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.01%	333K	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Surrozen, Inc. Portfolio share: 0.00% Portfolio value: 135K Avg. open price: N/A Current price: $0.05 P/L: N/A N/A Q3 2021	share	0.00%	135K	N/A	$0.05	N/A	N/A Q3 2021
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.47 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.47	N/A	Sold -100.00% shares Q3 2022
Biotechnology Evelo Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.94 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.94	N/A	Sold -100.00% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $84.08 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$84.08	N/A	Sold -100.00% shares Q3 2022
Biotechnology Adverum Biotechnologies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.66 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.66	N/A	Sold -100.00% shares Q3 2022
Biotechnology Exelixis, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $17.22 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$17.22	N/A	Sold -100.00% shares Q3 2022
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.05 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.05	N/A	Sold -100.00% shares Q3 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.4 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.4	N/A	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $36.66 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$36.66	N/A	Sold -100.00% shares Q3 2022
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.1 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.1	N/A	Sold -100.00% shares Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $21.42 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$21.42	N/A	Sold -100.00% shares Q3 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.79 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.79	N/A	Sold -100.00% shares Q3 2022
Biotechnology Cerevel Therapeutics Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $28.31 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$28.31	N/A	Sold -100.00% shares Q3 2022
Biotechnology Silverback Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $13.76 Current price: $5.87 P/L: -57.35% Sold -100.00% shares Q3 2022	share	0.00%	0	$13.76	$5.87	-57.35%	Sold -100.00% shares Q3 2022

Showing TOP 89 ECOR1 CAPITAL's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ECOR1 CAPITAL, LLC?

The biggest position of the ECOR1 CAPITAL, LLC is Prothena Corporation plc (PRTA) with 20.73% portfolio share worth of 702.36M US dollars.

Top 5 ECOR1 CAPITAL's holdings represent 50.73% of the portfolio:

Prothena Corporation plc (PRTA) – 20.73%
Apellis Pharmaceuticals, Inc. (APLS) – 10.45%
Sarepta Therapeutics, Inc. (SRPT) – 9.79%
AnaptysBio, Inc. (ANAB) – 5.66%
Arvinas, Inc. (ARVN) – 4.1%

Who is the portfolio manager of ECOR1 CAPITAL, LLC?

The portfolio manager of the ECOR1 CAPITAL, LLC is .

What is the total asset value of the ECOR1 CAPITAL, LLC portfolio?

ECOR1 CAPITAL, LLC total asset value (portfolio value) is 3.39B US dollars.

Who is ?

is the portfolio manager of the ECOR1 CAPITAL, LLC.

What is (ECOR1 CAPITAL, LLC) fund performance?

ECOR1 CAPITAL's quarterly performance is +21.29%, annualy -35.44%. In the past 3 years, the value of 's portfolio has decreased by -39%. In the past 5 years, the value of the portfolio has decreased by -32%.

What is the ECOR1 CAPITAL, LLC CIK?

ECOR1 CAPITAL's Central Index Key is 0001587114 .

ECOR1 CAPITAL, LLC Holdings

ECOR1 CAPITAL, LLC portfolio value:

ECOR1 CAPITAL, LLC quarter portfolio value change:

ECOR1 CAPITAL, LLC 1 year portfolio value change:

ECOR1 CAPITAL, LLC 3 years portfolio value change:

ECOR1 CAPITAL, LLC 5 years portfolio value change: